This is a summary of the European Public Assessment Report (EPAR) for Epivir. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Epivir.
Therapeutic Indication
### Therapeutic indication Epivir is indicated as part of antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (HIV)-infected adults and children.
Therapeutic Area (MeSH)
ATC Code
J05AF05
ATC Item
lamivudine
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| lamivudine | N/A | 拉米夫定 |
EMA Name
Epivir
Medicine Name
Epivir
Aliases
N/ANo risk management plan link.
